Daewoong Pharma (069620) — Net Asset Momentum
Daewoong Pharma (069620) recorded a net asset momentum of 15.4% as of December 2024, with net assets of ₩926.98 Billion KRW. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See defensive interval ratio of Daewoong Pharma to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Daewoong Pharma Net Asset Momentum (2007–2024)
This chart tracks Daewoong Pharma's year-over-year net asset growth across 16 annual reporting periods from 2007 to 2024. The most recent momentum reading is +15.4%, with net assets of ₩926.98 Billion KRW as of December 2024. Read debt load of Daewoong Pharma for a breakdown of total debt and financial obligations.
Annual Net Asset History for Daewoong Pharma (2007–2024)
The table below shows the complete annual net asset history for Daewoong Pharma from 2007 to 2024, covering 16 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see market value of Daewoong Pharma.
| Year | Net Assets (KRW) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | ₩926.98 Billion | ₩1.98 Trillion | ₩1.05 Trillion | ▲ +15.4% |
| 2023 | ₩802.97 Billion | ₩1.57 Trillion | ₩762.77 Billion | ▲ +8.3% |
| 2022 | ₩741.22 Billion | ₩1.56 Trillion | ₩822.12 Billion | ▲ +5.5% |
| 2021 | ₩702.41 Billion | ₩1.42 Trillion | ₩712.77 Billion | ▲ +1.0% |
| 2020 | ₩695.25 Billion | ₩1.37 Trillion | ₩671.66 Billion | ▲ +9.3% |
| 2019 | ₩635.92 Billion | ₩1.25 Trillion | ₩609.75 Billion | ▲ +4.6% |
| 2018 | ₩607.81 Billion | ₩1.21 Trillion | ₩600.04 Billion | ▼ -3.8% |
| 2017 | ₩631.54 Billion | ₩1.21 Trillion | ₩581.99 Billion | ▲ +4.5% |
| 2016 | ₩604.55 Billion | ₩1.14 Trillion | ₩540.15 Billion | ▲ +4.2% |
| 2015 | ₩580.24 Billion | ₩944.53 Billion | ₩364.29 Billion | ▲ +27.4% |
| 2014 | ₩455.51 Billion | ₩694.26 Billion | ₩238.76 Billion | ▲ +4.0% |
| 2013 | ₩437.96 Billion | ₩579.01 Billion | ₩141.05 Billion | ▲ +13.3% |
| 2012 | ₩386.59 Billion | ₩482.34 Billion | ₩95.76 Billion | ▲ +6.7% |
| 2011 | ₩362.42 Billion | ₩498.46 Billion | ₩136.04 Billion | ▲ +30.0% |
| 2008 | ₩278.85 Billion | ₩486.24 Billion | ₩207.39 Billion | ▲ +3.4% |
| 2007 | ₩269.57 Billion | ₩392.81 Billion | ₩123.24 Billion | — |